KAPIL GOPAL
Medical Practice in Delaware

License number
Pennsylvania MD423818
Category
Medicine
Type
Medical Physician and Surgeon
Address
Address 2
Delaware
Media, PA 19086

Personal information

See more information about KAPIL GOPAL at radaris.com
Name
Address
Phone
Kapil Gopal
145 13Th St, Philadelphia, PA 19107
Kapil Gopal
145 13Th St, Philadelphia, PA 19107
Kapil Gopal
1600 Walnut St, Philadelphia, PA 19103
Kapil Gopal
303 Bickmore Dr, Wallingford, PA 19086
Kapil Gopal
950 Walnut St, Philadelphia, PA 19107

Organization information

See more information about KAPIL GOPAL at bizstanding.com

Kapil Gopal

303 Bickmore Dr, Media, PA 19086

Status:
Inactive
Industry:
Medical Doctor's Office
Principal:
Kapil Gobal Principal, inactive

Professional information

Kapil Gopal Photo 1

Global Myocardial Perfusion Catheter

US Patent:
2006025, Nov 16, 2006
Filed:
Sep 16, 2004
Appl. No.:
10/572238
Inventors:
Charles Bridges - Villanova PA, US
Kapil Gopal - Wallingford PA, US
Assignee:
The Trustees of the University of Pennsylvania - Philadelphia PA
International Classification:
A61M 29/00
US Classification:
604101050
Abstract:
A catheter (A, B) and method for retrograde perfusion of the heart through the coronary sinus is provided. In one embodiment, the catheter (A, B) has a pair of separate balloons (A, B, A, B) that are located side-by-side on its distal end (A, B) and that can be positioned and expanded on opposite sides of the coronary sinus ostium to anchor the catheter to the coronary sinus and to form an occlusive seal of the coronary sinus adjacent its ostium. Alternatively, a single asymmetric “dumbbell” or “hourglass” shaped balloon can be used such that one portion of the balloon inflates in the right atrium, and thereafter, the other portion of the balloon is inflated at a location crossing the ostium and extends into the coronary sinus to occlude the ostium through radial expansion against the sinus at the ostium. The catheter and its method of use provide a tighter seal and improve distribution of cardioplegia and/or other substances, such as drugs or gene therapy vectors, to the myocardium.